Literature DB >> 27088809

Prion 2016 Oral Abstracts.

.   

Abstract

Entities:  

Year:  2016        PMID： 27088809      PMCID： PMC7043319          DOI： 10.1080/19336896.2016.1163103

Source DB:  PubMed          Journal:  Prion        ISSN： 1933-6896            Impact factor:   3.931


× No keyword cloud information.
  14 in total

1.  Natural and synthetic prion structure from X-ray fiber diffraction.

Authors:  Holger Wille; Wen Bian; Michele McDonald; Amy Kendall; David W Colby; Lillian Bloch; Julian Ollesch; Alexander L Borovinskiy; Fred E Cohen; Stanley B Prusiner; Gerald Stubbs
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-28       Impact factor: 11.205

2.  Mode of action of the antiprion drugs 6AP and GA on ribosome assisted protein folding.

Authors:  Suzana Dos Reis; Yanhong Pang; Neelanjan Vishnu; Cécile Voisset; Hervé Galons; Marc Blondel; Suparna Sanyal
Journal:  Biochimie       Date:  2011-03-17       Impact factor: 4.079

3.  Isolation of drugs active against mammalian prions using a yeast-based screening assay.

Authors:  Stéphane Bach; Nicolas Talarek; Thibault Andrieu; Jean-Michel Vierfond; Yvette Mettey; Hervé Galons; Dominique Dormont; Laurent Meijer; Christophe Cullin; Marc Blondel
Journal:  Nat Biotechnol       Date:  2003-08-10       Impact factor: 54.908

4.  The antiprion compound 6-aminophenanthridine inhibits the protein folding activity of the ribosome by direct competition.

Authors:  Yanhong Pang; Sriram Kurella; Cécile Voisset; Dibyendu Samanta; Debapriya Banerjee; Ariane Schabe; Chanchal Das Gupta; Hervé Galons; Marc Blondel; Suparna Sanyal
Journal:  J Biol Chem       Date:  2013-05-14       Impact factor: 5.157

Review 5.  Tools for the study of ribosome-borne protein folding activity.

Authors:  Cécile Voisset; Jean-Yves Thuret; Déborah Tribouillard-Tanvier; Sven J Saupe; Marc Blondel
Journal:  Biotechnol J       Date:  2008-08       Impact factor: 4.677

6.  Amyloid fibrils of the HET-s(218-289) prion form a beta solenoid with a triangular hydrophobic core.

Authors:  Christian Wasmer; Adam Lange; Hélène Van Melckebeke; Ansgar B Siemer; Roland Riek; Beat H Meier
Journal:  Science       Date:  2008-03-14       Impact factor: 47.728

7.  Antiprion drugs 6-aminophenanthridine and guanabenz reduce PABPN1 toxicity and aggregation in oculopharyngeal muscular dystrophy.

Authors:  Nicolas Barbezier; Aymeric Chartier; Yannick Bidet; Anja Buttstedt; Cécile Voisset; Hervé Galons; Marc Blondel; Elisabeth Schwarz; Martine Simonelig
Journal:  EMBO Mol Med       Date:  2011-01       Impact factor: 12.137

Review 8.  Protein folding activity of the ribosome (PFAR) -- a target for antiprion compounds.

Authors:  Debapriya Banerjee; Suparna Sanyal
Journal:  Viruses       Date:  2014-10-23       Impact factor: 5.048

9.  Protein folding activity of ribosomal RNA is a selective target of two unrelated antiprion drugs.

Authors:  Déborah Tribouillard-Tanvier; Suzana Dos Reis; Fabienne Gug; Cécile Voisset; Vincent Béringue; Raimon Sabate; Ema Kikovska; Nicolas Talarek; Stéphane Bach; Chenhui Huang; Nathalie Desban; Sven J Saupe; Surachai Supattapone; Jean-Yves Thuret; Stéphane Chédin; Didier Vilette; Hervé Galons; Suparna Sanyal; Marc Blondel
Journal:  PLoS One       Date:  2008-05-14       Impact factor: 3.240

10.  The toll-like receptor agonist imiquimod is active against prions.

Authors:  Nassima Oumata; Phu Hai Nguyen; Vincent Beringue; Flavie Soubigou; Yanhong Pang; Nathalie Desban; Catherine Massacrier; Yannis Morel; Carine Paturel; Marie-Astrid Contesse; Serge Bouaziz; Suparna Sanyal; Hervé Galons; Marc Blondel; Cécile Voisset
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.